Library Item - Page 600 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Can improvements in muscle quality improve fitness levels in type 2 diabetics?

Can improvements in muscle quality improve fitness levels in type 2 diabetics?

Posted by on Oct 11, 2015 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether improved muscle quality is associated with improved fitness levels in type 2 diabetics. Some background Muscles in patients with type 2 diabetes (T2D) have a reduced ability to take up glucose from the blood. Patients have a high muscle mass and a reduction in muscle quality as a result. A reduction in...

Read More

Ipilimumab-induced hypophysitis in advanced melanoma

Posted by on Oct 11, 2015 in Melanoma | 0 comments

In a nutshell The authors analyzed the occurrence, management and risk factors of hypophysitis (a complication of the immune system following ipilimumab [Yervoy] therapy) in advanced melanoma patients.   Some background In advanced melanoma (stage III/IV), cancer spreads rapidly from the skin to other parts of the body....

Read More

Can a combination of targeted treatments work better than one in non-small cell lung cancer?

Can a combination of targeted treatments work better than one in non-small cell lung cancer?

Posted by on Oct 10, 2015 in Lung cancer | 0 comments

In a nutshell This study investigated the effect of erlotinib (Tarceva) with high dose celecoxib (Celebrex) in patients with advanced non-small cell lung cancer. Some background Some non-small cell lung cancers develop and grow due to a mutation (abnormality) in the epidermal growth factor receptor (EGFR) gene. EGFR tyrosine kinase inhibitors...

Read More

Combining targeted therapies: the benefits of directly targeting HER2+ breast cancer

Combining targeted therapies: the benefits of directly targeting HER2+ breast cancer

Posted by on Oct 10, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine the effectiveness of targeted treatments and also compared combination therapies. Some background HER2 positive breast cancer is associated with the over-expression (production) of the human epidermal growth factor receptor 2 (HER2+). HER2+ breast cancer is known to be more aggressive with a poorer...

Read More

Gynecomastia treatment in prostate cancer

Gynecomastia treatment in prostate cancer

Posted by on Oct 10, 2015 in Prostate cancer | 0 comments

In a nutshell The authors determined the treatment options available for gynecomastia in prostate cancer patients.  Some background Hormone therapy is a common treatment for prostate cancer. It targets the male sex hormones active in prostate cancer, such as testosterone. Bicalutamide (Casodex, Cosudex, Calutide) is a common hormonal drug...

Read More